drugset / Press release
Material Information - The China NMPA has Accepted the Marketing Authorization Application of Ropeginterferon alfa-2b for ET
2025-07-16 · PharmaEssentia · original pharmaessentia.com ↗
Download Material Information - The China NMPA has Accepted the Marketing Authorization Application of Ropeginterferon alfa-2b for ET Previous Next
The release as fetched from its publisher. pharmaessentia.com ↗